If a drug company set out to market a miracle pill to insecure young women, it couldn’t do better than the strategy Ortho-McNeil Pharmaceutical has come up with. In multipage advertisements appearing in magazines such as Glamour and Shape, Ortho uses close-up photos of gorgeous models to plug its Ortho Tri-Cyclen birth control pill as a “beauty aid” for “women 15 and over.” One ad calls it “the first pill proven to control blemishes as well as prevent pregnancy.” Oh, that.

A double-blind controlled study commissioned by Ortho found that its drug improved acne in 80 percent of users, and last year Ortho became the first drug company to gain approval from the Food and Drug Administration to market a birth control pill as a hormonal treatment for moderate acne.

Should dermatologists be prescribing birth control pills? Dr. Seth Matarasso, a San Francisco dermatologist, says his young female patients who have seen the Ortho Tri-Cyclen ads routinely ask him about the drug as an acne treatment. However, he is not quick to prescribe it to his patients. “Where do birth control pills fit in? For me, they’re almost a fallback,” Matarasso says, noting that he tries topical regimens, antibacterials, and even the prescription drug Accutane—which has serious side effects—before he’ll prescribe the Pill. “I would not put a 15-year-old on any systemic medication without having a frank discussion with her, her gynecologist, and her parents.”

Despite the fact that the ad campaign targets anxious teens—who may not understand the potential dangers and side effects of birth control pills—the ads have caused little controversy among doctors.

“Some people say facetiously that we should have all women on birth control from age 15 to 50,” says Dr. Elena Gates, chief OB-GYN at the University of California’s Mount Zion Medical Center. Gates calls Ortho Tri-Cyclen a prime example of “a good new drug,” but she acknowledges, “You need to be cautious that advertisers aren’t creating a need where one doesn’t exist.”

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

Share your feedback: We’re planning to launch a new version of the comments section. Help us test it.